ZCMD
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Trades well below book value, but value is eroded by negative earnings.
- Low P/S (0.70)
- Low P/B (0.32)
- No P/E due to losses
- No Graham Number available
Revenue growth of -23.2% suggests a shrinking business.
- Negative revenue growth
- Negative profit margins
Consistent and severe destruction of shareholder value over multiple timeframes.
- 5Y Change -98.6%
- 1Y Change -76.2%
Financial health is the only strong pillar, preventing immediate bankruptcy risk.
- Zero debt
- High current ratio
- Piotroski 6/9
- Negative ROE/ROA
Non-dividend paying growth/distressed stock.
- No dividend paid
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ZCMD and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ZCMD
Zhongchao Inc.
Primary
|
-98.6% | -97.8% | -76.2% | -65.0% | +13.5% | -2.1% |
|
ALUR
Allurion Technologies Inc.
Peer
|
-99.8% | -99.8% | -84.6% | -75.5% | -69.7% | -11.7% |
|
EVGN
Evogene Ltd.
Peer
|
-98.3% | -86.8% | -23.5% | -45.0% | +5.7% | -0.8% |
|
BMRA
Biomerica, Inc.
Peer
|
-95.7% | -88.5% | -46.5% | -34.3% | -3.0% | 0.0% |
|
IMRN
Immuron Limited
Peer
|
-85.9% | -59.6% | -51.9% | -61.7% | -3.3% | -1.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ZCMD
Zhongchao Inc.
|
BEARISH | $7.92M | - | -24.9% | -55.5% | $2.06 | |
|
ALUR
Allurion Technologies Inc.
|
BEARISH | $7.92M | - | -% | -187.9% | $0.53 | Compare |
|
EVGN
Evogene Ltd.
|
BEARISH | $7.95M | - | -100.7% | -220.2% | $0.8 | Compare |
|
BMRA
Biomerica, Inc.
|
BEARISH | $7.76M | - | -84.3% | -90.3% | $2.57 | Compare |
|
IMRN
Immuron Limited
|
BEARISH | $8.1M | - | -39.7% | -62.1% | $0.79 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning ZCMD from our newsroom.